Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
Cleerly
Precision heart care platform analyzing coronary CT angiography to evaluate plaque buildup.
What they do
The company provides artificial intelligence software that analyzes non-invasive coronary CT angiograms to measure and characterize plaque in heart arteries. It helps cardiologists identify heart disease before patients exhibit warning signs.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Cardiovascular diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Denver, USA
- Region
- North America
- Founded
- 2017
- Total funding
- $248M raised
Notable investors: T. Rowe Price, Fidelity, Sands Capital, LRVHealth.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Bridging the Last Mile of Acute Cardiology: Synthesized 3D Vectorcardiography at Home
Dr. Dereck Mush, MD, MBA
The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA
Menopause benefits are expanding past hot flashes into cardiovascular and bone health
Dr. Dereck Mush, MD, MBA